Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis.

Tadeu Diniz RamosJohnatas Dutra SilvaAlessandra Marcia da Fonseca-MartinsJuliana Elena da Silveira PrattiLuan Firmino-CruzDiogo Maciel-OliveiraJulio Souza Dos-SantosJoão Ivo Nunes TenorioAlmair Ferreira de AraujoCélio Geraldo Freire-de-LimaBruno Lourenço DiazFernanda Ferreira CruzPatricia Rieken Macedo RoccoHerbert Leonel de Mattos Guedes

Published in: Stem cell research & therapy (2020)

Combination treatment of cutaneous leishmaniasis with AD-MSCs and meglumine antimoniate may be a viable alternative.

Keyphrases

adipose tissue
bone marrow
mesenchymal stem cells
high fat diet
stem cells
type diabetes
plasmodium falciparum
replacement therapy
cell therapy
trypanosoma cruzi